PharmaNews.eu
  • Home
  • Business
  • R&D
  • EC
  • EMA
  • Events
  • Open Calls

Pfizer

Pfizer

PfizerFounded in 1849, Pfizer is the world's largest research-based pharmaceutical company. Pfizer is taking new approaches to advancing better health as it discovers, develops, manufactures and delivers quality, safe and effective prescription medicines to treat and help prevent disease for both people and animals. Pfizer also partners with healthcare providers, governments and local communities around the world to expand access to medicines and to provide better quality health care and health system support. At Pfizer, more than 84,000 colleagues in more than 90 countries work every day to help people stay happier and healthier longer and to reduce the human and economic burden of disease worldwide. For more information visit www.pfizer.com.

Pfizer RSS Channel

Filters
List of articles in category Pfizer
Title Published Date
Pfizer Conducts First "Virtual" Clinical Trial Allowing Patients to Participate Regardless of Geography 08 June 2011
Pfizer Files for European Regulatory Review of Axitinib 01 June 2011
ELIQUIS® (apixaban) Approved in Europe for Preventing Venous Thromboembolism after Elective Hip or Knee Replacement 21 May 2011
Pfizer Reports First-Quarter 2011 Results 03 May 2011
XIAPEX® Authorized in the European Union (EU) for Dupuytren's Contracture 28 February 2011
New AVERROES Data Demonstrate Investigational Apixaban Superior to Aspirin 13 February 2011
Pfizer and Protalix BioTherapeutics Announce Submission of taliglucerase alfa for European Marketing Authorization 29 November 2010
Adding INSPRA® (eplerenone) to Standard Therapy Significantly Reduces the Risk of CV Mortality and Morbidity 15 November 2010
Alpine Mountaineer and Alzheimer's Advocate to Climb Highest Peak on Each Continent 09 November 2010
Updated Pfizer Pipeline Focuses on Value, Unmet Medical Need 29 September 2010
Pfizer Reports Second-Quarter 2010 Results 11 August 2010
New CELEBREX® (celecoxib) Study Using Novel Endpoint 22 June 2010
Phase 3 Study Showed MACUGEN® Improved Vision Over Standard Of Care In Patients With Diabetic Macular Edema 07 June 2010
Pfizer and Medivation Announce Results From Two Phase 3 Studies in Dimebon 04 March 2010
New Pfizer Pipeline Shows Progress And Growth In Vaccines, Biologics And High-Priority Disease Areas 28 January 2010
Pfizer and Auxilium Announce Commencement of European Regulatory Review of XIAFLEX 22 January 2010
European Commission Approves New Intravenous Formulation Of Pfizer's Revatio® 05 January 2010
Pfizer Receives European Authorization For Prevenar 13 14 December 2009
Pfizer Submits New Pediatric Data For Lipitor® (Atorvastatin) To The European Medicines Agency (EMEA) 18 November 2009
Pfizer And Wyeth Become One: Working Together For A Healthier World™ 16 October 2009

Page 3 of 4

  • Start
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next
  • End
  1. You are here:  
  2. Home
  3. Pfizer

About

  • Home
  • Terms and Conditions
  • Contact

Advertise

Top News Channels

  • Business
  • Research
  • EMA
  • Events

Follow us

Didn't we got you connected? If not, please note the following magic buttons:

  • Facebook
  • Twitter
  • RSS 2.0
  • Atom 1.0

Newsletter

Stay updated on the latest Pharma News. Subscribe now, it's free!

Copyright © 2021 PharmaNews.eu. All Rights Reserved.